How do we best get country representation involved; who, when & how. We should definitely have that discussion when we get together next!
···
Fredrik Winsnes
Cloud Services Program Director
USAID-NetHope
Global Broadband & Innovation Alliance
+1 (425) 445 4599
www.nethope.org
fredrik.winsnes@nethope.org
gbiportal.net / nethope.org
From: mhealth-registry@googlegroups.com [mailto:mhealth-registry@googlegroups.com]
On Behalf Of Paul Biondich
Sent: Tuesday, March 06, 2012 6:12 PM
To: mhealth-registry@googlegroups.com
Cc: mhealth-registry-devs@googlegroups.com
Subject: Re: Doodle Poll for Next Fred Call - Please Respond by eod Wed March 7
Fredrik, sounds good. I think the key is to get the work focused on actual, country-identified needs ASAP… so that we’re acting against real needs and not perceived ones. That’s IMO, one of the only dangers of developing use cases and
persona without country representation.
In the short term… Ed, Matt, and Bob are important stakeholders that can serve as country “proxies.”
-Paul
On Tue, Mar 6, 2012 at 8:14 PM, Fredrik Winsnes (NH) fredrik.winsnes@nethope.org wrote:
Hi Lorrine,
I am not completely sure who are all registered in the googlegroups above, but we should make sure that Justin Fyfe and Ted Scott from Mohawk College,
Jorn Braa (jbraa@ifi.uio.no) and Bob Joliffe (bobjolliffe@gmail.com) from DHIS as well as Eduardo Jezierski from
InSTEDD are invited as well. I will send them this and encourage them to sign up for the group. (I am not quite sure how to list the names of all members in the group)
I had a good discussion with Matt & Justin earlier today and we agreed if may be good to spend some time to discuss/brainstorm on the following topics:
-
Use cases (for the Facility Registry Service itself as well as what we envision ‘client applications’ ought to be able to do interfacing with the Registry Service)
-
Personas: Who/what type of users will be using the Facility Registry Service and what levels if permissions would need to be established for various roles
-
Scope boundaries between the “Service” and “Clients” (what sample/illustrative “clients” do we plan on developing as part of this project); this was touched on in the last meeting and I am sure there may be some additional
thinking on this to be shared.
-
Further review on progress on APIs
All the best,
Fredrik
From:
mhealth-registry-devs@googlegroups.com [mailto:mhealth-registry-devs@googlegroups.com]
On Behalf Of Lorinne Banister
Sent: Tuesday, March 06, 2012 10:56 AM
To:
mhealth-registry-devs@googlegroups.com;
mhealth-registry@googlegroups.com
Subject: Doodle Poll for Next Fred Call - Please Respond by eod Wed March 7
All – Below is the eMail I sent out after the call last month. There is a doodle poll to determine the next meeting for March.
Only 4 people have responded. Please respond by end of day tomorrow!!!
http://www.doodle.com/cnid7miam77kyznc
-Lorinne
From:
mhealth-registry-devs@googlegroups.com
[mailto:mhealth-registry-devs@googlegroups.com] On Behalf Of Lorinne Banister
Sent: Thursday, February 23, 2012 6:10 PM
To: mhealth-registry@googlegroups.com;
mhealth-registry-devs@googlegroups.com
Subject: FRED Project Call - Minutes/Recording Link 2-23-12
All,
Attached to this eMail are the summary minutes from today’s call – they are also posted on the sharepoint site
https://confluence.dimagi.com/display/facilityregistry
Below is a link to the recording for those of you that missed the call.
http://www.conferenceplayback.com/stream/96494533/07759101.mp3
Below is a doodle poll to help organize the next call – Please respond by Wed Feb 29th.
http://www.doodle.com/cnid7miam77kyznc
Additionally if you have time, please verify your name and contact info on the participants list on the sharepoint site and update or add your name if necessary.
Let me know if you have any questions.
Thanks,
Lorinne
Lorinne Banister
PMP
Technical Project Manager HI-PPP
Regenstrief Institute
317.423.5669 (w)|317.501.5025 ©
lbanister@regenstrief.org
Confidentiality Notice: The contents of this message and any files transmitted with it may contain confidential and/or privileged information
and are intended solely for the use of the named addressee(s). Additionally, the information contained herein may have been disclosed to you from medical records with confidentiality protected by federal and state laws. Federal regulations and State laws prohibit
you from making further disclosure of such information without the specific written consent of the person to whom the information pertains or as otherwise permitted by such regulations. A general authorization for the release of medical or other information
is not sufficient for this purpose. If you have received this message in error, please notify the sender by return e-mail and delete the original message. Any retention, disclosure, copying, distribution or use of this information by anyone other than the
intended recipient is strictly prohibited.
